Since our inception in 2015 in Denmark, Liva has been leading the way in the field of digital therapeutics. Our ambition is to prevent, manage and treat chronic disease through behaviour and lifestyle change, with a keen focus on cardiometabolic conditions. Over the years, we have expanded our reach across national healthcare systems and geographies, marking our presence as a global force for advancing health outcomes.
We integrate seamlessly into healthcare systems offering a unique hybrid digital therapeutics platform that combines personalised, one-on-one lifestyle coaching with innovative digital-first delivery.
Our team of dedicated healthcare professionals create tailored behaviour and lifestyle change programs to support patients in their journey to prevent, manage and treat obesity, type 2 diabetes, pre-diabetes and other cardiometabolic conditions. The safety and efficacy of our digital therapeutic programmes are well-supported by extensive evidence from randomised controlled trials (RCTs) and other clinical studies.
Headquartered in Copenhagen and London, Liva is at the forefront of delivering industry-leading lifestyle change and chronic disease management programmes across Europe. Our collaborations with healthcare systems, including the NHS, as well as partnerships with some of the world’s largest life science companies and health insurers allow us to impact lives on a large scale.
COO & Deputy CEO
CCO & UK GM
Founders & Board of Directors
Co-Founder, Medical Director
Maj Invest, Copenhagen
by Elena Rey Velasco, Liva Healthcare Making lifestyle changes can often feel like a tough and uncertain journey. Whether it’s about being more active, feeling better, or just picking up healthier habits, there’s a powerful tool that can give
Liva is delighted to introduce Michel Lussier as the new Chair of the Board as the business gears up to accelerate expansion to new markets.
LONDON, United Kingdom, August 16, 2023 Liva is delighted to be provisionally selected as one of the leading digital therapeutics platforms to offer hybrid weight-loss